Grant: Discovery Grants Program - Individual
University of Toronto
$64,000.00
Integrated biosensors for organ-on-a-chip and physiological monitoring platforms
EF 2022-23
Résumé
Advances in tissue engineering and microfluidics have enabled the creation of "organ-on-a-chip" devices that mimic the functions of human organs and tissues better than conventional Petri dish-based cell culture systems. These technologies hold great promise for disease modeling and drug discovery. Despite their enormous potential, a persistent limitation of organ-on-a-chip platforms is that they rely on manual, off-chip analytical methods, which creates an analysis bottleneck and limits the value of these platforms. Integration of on-chip sensors could enable continuous, higher-throughput, and higher-content analyses. Strikingly, there have been significant advances in incorporating biosensors into point-of-care and some wearable microfluidic devices for diagnostics and health monitoring, but integration in organ-on-a-chip platforms has not kept up because of the engineering challenges involved. Here, we propose a research program to directly address these challenges by leveraging our novel microfluidic and sensor technologies to engineer organ-on-a-chip platforms with on-chip biosensing capabilities and microfluidic devices for body fluid biomarker detection. To do so, we will investigate fundamental aspects of biotransport and biosensing to enable biomolecule detection in dynamic microfluidic environments; develop and adapt sensitive on-chip sensors to measure biological barrier integrity, microtissue contraction, and dissolved oxygen and other analyte concentrations in organ-on-a-chip platforms; and design soft microfluidic devices for urine volume measurement and biomarker detection. This knowledge will be applied to create augmented organ-on-a-chip models of the blood-brain barrier and injured heart and to advance wearables for remote monitoring of infants with heart failure. The graduate and undergraduate students trained in this research program will be equipped with the scientific and professional skills required to apply the knowledge generated by their research for long-term impact and to lead bold new initiatives in biosensing, biomicrofluidics, and biotechnology in the future.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2022-04375
Name nom
Simmons, Craig
Department département
Mechanical and Industrial Engineering - Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
64000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1
Partie
1
Nb partie
5
Application title
Integrated biosensors for organ-on-a-chip and physiological monitoring platforms
Application summary
Advances in tissue engineering and microfluidics have enabled the creation of "organ-on-a-chip" devices that mimic the functions of human organs and tissues better than conventional Petri dish-based cell culture systems. These technologies hold great promise for disease modeling and drug discovery. Despite their enormous potential, a persistent limitation of organ-on-a-chip platforms is that they rely on manual, off-chip analytical methods, which creates an analysis bottleneck and limits the value of these platforms. Integration of on-chip sensors could enable continuous, higher-throughput, and higher-content analyses. Strikingly, there have been significant advances in incorporating biosensors into point-of-care and some wearable microfluidic devices for diagnostics and health monitoring, but integration in organ-on-a-chip platforms has not kept up because of the engineering challenges involved. Here, we propose a research program to directly address these challenges by leveraging our novel microfluidic and sensor technologies to engineer organ-on-a-chip platforms with on-chip biosensing capabilities and microfluidic devices for body fluid biomarker detection. To do so, we will investigate fundamental aspects of biotransport and biosensing to enable biomolecule detection in dynamic microfluidic environments; develop and adapt sensitive on-chip sensors to measure biological barrier integrity, microtissue contraction, and dissolved oxygen and other analyte concentrations in organ-on-a-chip platforms; and design soft microfluidic devices for urine volume measurement and biomarker detection. This knowledge will be applied to create augmented organ-on-a-chip models of the blood-brain barrier and injured heart and to advance wearables for remote monitoring of infants with heart failure. The graduate and undergraduate students trained in this research program will be equipped with the scientific and professional skills required to apply the knowledge generated by their research for long-term impact and to lead bold new initiatives in biosensing, biomicrofluidics, and biotechnology in the future.